A Supplement Facts panel can tell you how much of a nutrient the product contains. For a proprietary blend, it usually cannot: US labelling rules require the blend’s total weight and the names of its ingredients, but not the amount of each ingredient. That single rule explains most of the “the label doesn’t say” puzzles you meet on supplement pages, including the one on the men’s-health product this article used to review.
Illustration: the panel shows a total blend weight — not the amount of each ingredient inside it.
What must a Supplement Facts panel disclose?
Four things, at minimum: serving size, the amount per serving of each dietary ingredient, the percent daily value where one exists, and the list of ingredients in descending order of weight. For a proprietary blend, the rules add a specific allowance that changes what you can calculate.
| Panel element | Required? | What you can do with it |
|---|---|---|
| Serving size | Yes | Work out how many days a bottle covers |
| Amount per serving, individual nutrient | Yes | Compare against a trial dose |
| Percent daily value | Where established | Context for vitamins and minerals |
| Proprietary blend total weight | Yes | A ceiling on the blend, not on any ingredient |
| Proprietary blend ingredient names | Yes, in descending weight | Order, not quantity |
| Amount of each ingredient in a blend | No | Nothing — the number does not appear |
The last row is the one that matters. A 2023 review of proprietary blends states the position cleanly: the weight of the blend and the names of the ingredients must be declared, but not the amounts of the individual ingredients. As the authors put it, the amount of a dietary ingredient in a proprietary blend “is not available for calculating exposures in assessments of intakes or for determining doses in clinical trials.”
Read that consequence twice. It is not that the information is hard to find. It is that the label construction makes the per-ingredient dose uncalculable — by design, and lawfully.
Why does this matter more than it sounds?
Because every useful comparison needs a dose. A trial tests 500 mg of an extract; a bottle lists that extract inside a 900 mg blend with eleven other ingredients. You cannot tell whether you are getting the tested amount, a tenth of it, or ten times it.
This is why “clinically studied ingredient” is a weaker statement than it appears. The phrase can be true of an ingredient while being false as a description of the product: the ingredient was studied, at some dose, in some preparation, in some population — and none of those three facts travels with the blend.
There is a second, empirical problem. Where researchers have analysed finished products against their labels, discrepancies appear often. A 2024 case series of weight-loss supplements sold near US military installations found the majority had inaccurate labels and were rated no-go on a quality scorecard. A DNA-based authentication study of commercial herbal products found adulteration to be globally widespread. Neither study looked at the men’s-health category, and neither proves anything about a specific bottle — but together they establish that “the label says so” is not by itself a guarantee.
Who allowed proprietary blends, and why?
The allowance comes from a specific statute, not from a gap in enforcement. The Dietary Supplement Health and Education Act of 1994 (DSHEA) permits manufacturers to list non-nutrient dietary ingredients as a proprietary blend so a company can protect its formula.
Writing in the Journal of Nutrition in 2023, authors from the NIH Office of Dietary Supplements, the FDA Office of Dietary Supplement Programs, and the Consumer Healthcare Products Association set out the trade-off in plain terms: the blend’s total weight and the names of its ingredients must be declared, but not the amounts of the individual ingredients within the blend.
Their conclusion is the sentence worth memorising:
From label information, the amount of a dietary ingredient in a proprietary blend is not available for calculating exposures in assessments of intakes or for determining doses in clinical trials.
That is not a critic’s reading. It is what the regulators and the industry association jointly describe as the consequence of the rule.
Is a proprietary blend legal, and is it a red flag?
It is legal, and it is not by itself a red flag.
The allowance exists for a defensible reason: without it, a competing manufacturer could copy a tested formula from the label and undercut it. Formula protection is a real commercial interest, and it is the interest the statute names.
The problem is informational, not legal. A blend does not tell you what you are buying, and it produces a specific downstream failure: the product cannot be matched to any trial dose, because the per-ingredient quantity was never printed.
Where the red flag does sit is at the edges:
- A blend that hides a stimulant. Pre-workout reviews note that multi-ingredient formulas can contain banned substances as intentional ingredients or as contaminants, which is why athletes are advised to investigate every ingredient before use. You cannot investigate an amount that is not there.
- A blend used to conceal a filler-heavy formula. Total blend weight is a ceiling, not a distribution.
- A blend paired with a “clinically studied ingredients” claim. The phrase describes ingredients, not the dose in the bottle.
A single-ingredient product with a stated dose is not automatically better — it can still be underdosed or mislabelled. But it is checkable, and that is the difference that matters.
What can you actually check before buying?
Five checks, in descending order of usefulness. The first is decisive; the rest are filters.
- Is there a per-ingredient amount? If every active ingredient has a number in the “Amount Per Serving” column, the product can be compared with research. If a single line says “Proprietary Blend … 1,200 mg” and lists ten names after it, the comparison is impossible.
- Does the serving size match the trial dose? A label can disclose 500 mg while the serving is two capsules, and the trial used three servings a day.
- Is there a third-party certification mark? NSF Certified for Sport, USP Verified, and Informed Sport each involve testing the finished product, not just the label. Their absence means no independent check was published.
- Is the allergen and “other ingredients” list complete? Magnesium stearate and silicon dioxide are common and usually harmless; an undisclosed filler is a different matter.
- Does the page state a refund window and its conditions? This is a purchasing question rather than an evidence one, but it is the only term you can verify before paying.
Is a proprietary blend worth paying for?
This is the question the label cannot answer, and it is the one most buyers actually have. The honest answer depends on which of three situations you are in.
If the blend lists a single ingredient, the label is not hiding anything. A “blend” of one item with a total weight is a formatting choice, not a disclosure problem. You can still compare the dose against trials, because the amount is the whole blend.
If the blend lists several ingredients and you are buying it for one of them, the format works against you. Say a product leads with berberine in its marketing but the blend contains berberine, berberine hydrochloride, and four botanicals under one weight. You cannot tell whether you are getting 1,000 mg of the ingredient you wanted or 200 mg of it alongside 800 mg of the others. The trials that established the effect used a defined dose of one compound; this label cannot establish that you are receiving it.
If the blend is the only version available and the clinical literature is on the blend itself, the format is not a defect. Some formulas — certain multi-strain probiotic consortia and a few traditional botanical mixtures — are studied as a whole. Where the published trials tested the finished blend rather than its parts, per-ingredient amounts are not what the evidence rests on, and their absence means less.
The deciding question is therefore not “does this label say proprietary blend” but “was the thing that was tested the thing I am buying”. If the trials tested single compounds and the product sells a blend, you are paying for an unverifiable guess. If the trials tested the finished blend, you are buying exactly what was studied, and the missing per-ingredient numbers cost you nothing.
There is a fourth case worth naming, because it is the most common one on men’s-health and blood-sugar listings. The price is set by the blend’s total weight and the marketing story, not by any ingredient whose dose you can check. In that case the honest description is that you are buying an outcome the seller promises, with no way to audit the inputs. That may still be worth it to you, but the decision should be made knowing that, not because the label looked authoritative.
If check one fails, the remaining four cannot repair it. A product with no per-ingredient amounts is not unproven in some abstract sense; it is unverifiable by construction.
A worked example: the men’s-health listing
This article began as a review of a specific men’s-health capsule sold on the BuyGoods storefront. What could be confirmed was narrow: the listing names the product, places it in a men’s health collection, shows the seller as BuyGoods Inc, and displays a price. What could not be confirmed was the ingredient panel with amounts — the page was not retrievable when we tried, and no substitute source publishes a complete panel.
Rather than reconstruct a formula from secondary summaries, the honest output is this article. The product illustrates the general problem precisely: a buyer facing a listing with an unverifiable panel is not short of an opinion, they are short of a number.
If you are holding a specific bottle, the L. paracasei evidence page shows what a comparison looks like when both sides have numbers — four-field matching of strain, dose, schedule and formulation. If you are weighing finished products against each other, Gut Health Supplements Compared runs the same check across labels, and the GutSave review applies it to a single bottle that publishes no quantities at all.
Which page fits your situation: if you want the rule itself, stay here; if you already know the rule and need to match a labelled dose to a trial, go to the L. paracasei evidence page; if you are comparing several products before choosing, start with Gut Health Supplements Compared.
Frequently asked questions
Why do supplement labels say “proprietary blend”? It is a lawful way for a manufacturer to protect a formula while still disclosing what is in it. The trade-off is explicit in the rule: you learn the ingredients and the blend’s total weight, and you do not learn the individual amounts.
Is a proprietary blend illegal or unsafe? Neither. It is permitted and common. The issue is informational: the construction prevents per-ingredient dose comparison, so no claim about matching a study can be verified from the label alone.
Does a third-party seal fix this? Partly. NSF Certified for Sport, USP Verified and Informed Sport test the finished product for identity, potency and contaminants. That is more than a label check — but a potency result confirms the blend total, not the split between ingredients inside it.
Can I estimate an ingredient’s amount from the order of names? No. Ingredients in a blend are listed in descending order of weight, which tells you rank and nothing about magnitude. Two products with identical name order can differ tenfold in an individual ingredient.
Where can I read the actual labelling rule? The US Food and Drug Administration publishes the requirements for dietary supplement labelling, including the proprietary blend provision: https://www.fda.gov/food/dietary-supplements (accessed November 2, 2026).
How many ingredients can a proprietary blend hold? There is no cap in the regulation. Ten to fifteen ingredients under one weight figure is common, and the only quantity you see is the blend total — so the per-ingredient amount shrinks as the list grows. A 1,200 mg blend naming twelve ingredients cannot give any single one more than 1,200 mg, and in practice gives each far less.
If every product in a category uses a blend, what do I do? Buy the one that does not, or buy nothing. A category where no product discloses per-ingredient amounts has no checkable option, and the honest response is to read dose-dependent marketing claims in that category as unverified rather than to pick the least-bad label.
Should I avoid every proprietary blend product? No, and treating the format as an automatic disqualifier is the wrong rule. It depends on what the trials tested. Where the published studies used the finished blend — some multi-strain probiotic consortia, a few traditional botanical mixtures — a per-ingredient breakdown is not what the evidence rests on, and a label that gives one has added nothing you can use. Where the studies tested single compounds at defined doses, a blend that hides its split cannot be checked against them at all. The format is a problem only in the second case.
If I already bought one, is there anything I can check? Three things, none of them decisive. The refund window and its conditions are the only term you can enforce. The blend total divided by the number of ingredients gives an upper bound on any single one — almost always far below the studied dose. And if the seller publishes a Certificate of Analysis for the finished batch, that confirms the blend total, not the split inside it. None of these tells you the per-ingredient amount, because that figure is not required to exist anywhere in the supply chain.
Does this apply outside the United States? The DSHEA allowance is US law. The EU and UK take a different approach to supplement labelling, and a product sold in several markets may carry different panels. If you are comparing a US listing with a European one, check which panel you are reading before comparing doses.
Conclusions worth keeping
The panel is a disclosure document with a known gap. Learn where the gap is — the individual amounts inside a blend — and most supplement marketing claims become easy to sort: those that give you a dose you can check, and those that give you a list you cannot.
Sources
- Saldanha LG, Dwyer JT, Hardy CJ, MacKay DJ. Perspectives on the Use of Proprietary Blends in Dietary Supplements. J Nutr. 2023;153(5):1305-1308. NIH Office of Dietary Supplements, FDA Office of Dietary Supplement Programs, and CHPA: https://pubmed.ncbi.nlm.nih.gov/37004873/ (accessed November 2, 2026).
- Harty PS, Zabriskie HA, Erickson JL, Molling PE, Kerksick CM, Jagim AR. Multi-ingredient pre-workout supplements, safety implications, and performance outcomes: a brief review. J Int Soc Sports Nutr. 2018;15(1):41: https://pubmed.ncbi.nlm.nih.gov/30089501/ (accessed November 2, 2026).
- Label accuracy and quality of weight-loss dietary supplements sold near US military installations: https://pubmed.ncbi.nlm.nih.gov/39770990/ (accessed November 2, 2026).
- DNA-based authentication of commercial herbal products and the extent of adulteration: https://pubmed.ncbi.nlm.nih.gov/31708772/ (accessed November 2, 2026).
- US Food and Drug Administration, dietary supplement labelling requirements: https://www.fda.gov/food/dietary-supplements (accessed November 2, 2026).
Facts checked: 2 November 2026 · VitalRoundup Editorial Team · Reviewed by VitalRoundup Editorial Team (sources and label data re-checked) · How we review
Related notes
→ Every measured effect size, in one table
